Home

Laurus Labs Ltd PE Ratio

Image

Laurus Labs Ltd

NSE: LAURUSLABS

PE

233.9

Last updated on: Jan 15, 2025

Key Highlights

  • The P/E Ratio of Laurus Labs Ltd is 233.9 as of 15 Jan 14:08 PM .
  • The P/E Ratio of Laurus Labs Ltd changed from 13.5 on March 2020 to 131.5 on March 2024 . This represents a CAGR of 57.66% over 5 years.
  • The Latest Trading Price of Laurus Labs Ltd is ₹ 553.3 as of 15 Jan 13:53 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Laurus Labs Ltd

No data available

Company Fundamentals for Laurus Labs Ltd

Image

Laurus Labs Ltd

NSE: LAURUSLABS

Share Price

₹ 553.3

-14.95 (-2.63%)

stock direction

Last updated on: Jan 15, 2025

Market Price of Laurus Labs Ltd

1M

1Y

3Y

5Y

Monitoring Laurus Labs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 2025568.25
13 Jan 2025558.8
10 Jan 2025583.5
09 Jan 2025613.45
08 Jan 2025610.85
07 Jan 2025612.7
06 Jan 2025599.75
03 Jan 2025610.8
02 Jan 2025613.35
01 Jan 2025615.05

SWOT Analysis Of Laurus Labs Ltd

Strength

6

che

Weakness

2

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Laurus Labs Ltd

Asset Value vs Market Value of Laurus Labs Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Laurus Labs Ltd30637
Sun Pharmaceuticals Industries Ltd424382
Divis Laboratories Ltd159224
Cipla Ltd116943
Dr Reddys Laboratories Ltd111588

PE Ratio of Laurus Labs Ltd Explained

``

30637

Market cap

131

Earnings

233.9X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Laurus Labs Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Laurus Labs Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Laurus Labs Ltd

No data available

* All values are in %

About Laurus Labs Ltd

  • Laurus Labs is a science-led, fully integrated pharmaceutical and biotechnology manufacturing company with a leadership position in generic active pharmaceutical ingredients (APIs) in selected high-growth therapeutic areas of anti-retrovirals (ARVs), Hepatitis C and Oncology.
  • The company also manufactures APIs in oncology and other therapeutic areas, such as anti-asthma, ophthalmology, antidiabetics, cardiovascular, proton pump inhibitors (PPIs) amongst others.
  • The company currently operates 4 manufacturing facilities in Visakhapatnam, Andhra Pradesh.
  • Three of these facilities manufacture APIs and ingredients, while the fourth facility produces Finished Dosage Formulations (FDFs) and one API. The company's strategic and early investments in R&D and manufacturing infrastructure has enabled it to become one of the leading suppliers of APIs in the ARV therapeutic area to multi-national pharmaceutical formulation companies which cater to the large and fast-growing 'donor-funded access-to-medicines markets' of Sub-Saharan Africa, South-East Asia and Latin America.

Laurus Labs Ltd News Hub

Laurus Labs Ltd spurts 1.39%, up for five straight sessions

Laurus Labs Ltd rose for a fifth straight session today. The stock is quoting at Rs 443.5, up 1.39%

Read more

2024-08-21 00:00:00

Laurus Labs Ltd rises for third consecutive session

Laurus Labs Ltd gained for a third straight session today. The stock is quoting at Rs 435.5, up 1.4%

Read more

2024-08-19 00:00:00

Laurus Labs Ltd soars 4.39%

Laurus Labs Ltd is up for a third straight session in a row. The stock is quoting at Rs 496.5, up 4.

Read more

2024-09-05 00:00:00

Laurus Labs inaugurates new R&D center at IKP Knowledge Park

Laurus Labs announced the inauguration of its state of the art new R&D center at IKP Knowledge Park,

Read more

2024-09-16 00:00:00

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Laurus Labs Ltd

What is the current PE Ratio of Laurus Labs Ltd?

The Current PE Ratio of Laurus Labs Ltd is 233.85 as on 15 Jan 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 15 Jan 2025.

What was the PE Ratio of Laurus Labs Ltd last year?

The PE Ratio of Laurus Labs Ltd was 19.97 last year, now the PE ratio is 233.85, showing a year-on-year growth of 1071.0%.

What does the PE Ratio of Laurus Labs Ltd indicate about its stock?

The PE Ratio of Laurus Labs Ltd is 233.85. This ratio indicates that investors are willing to pay 233.85 times the earnings per share for each share of Laurus Labs Ltd.

What is the PE Ratio Growth of Laurus Labs Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Laurus Labs Ltd grew by 1071.0% whereas, the EPS ratio grew by 60.9.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions